Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Veerhealth Care Limited - 511523 - Outcome Of Board Meeting

 Dear Sir, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you about the outcome of the Meeting of the Board of Directors of the Company held today i.e. June 30, 2021 as under: 1. The Board has approved and taken on record the Audited Financial Results for the quarter and year ended March 31, 2021. 2. The Board has not recommended final dividend on equity shares of the Company for the financial year 2020-21. The Board Meeting commenced at 5.00 p.m. and concluded at 6.00 p.m. Kindly take the above information on record and oblige.
30-06-2021
Bigul

Annual report for Veerhealth Care Ltd. for FY-2021
30-06-2021
Bigul

Veerhealth Care Limited - 511523 - Board Meeting Intimation for Consider And Approval Of The Audited Financial Results For The Quarter And Financial Year Ended 31St March, 2021 And Recommendation Of Dividend, If Any.

 Veerhealth Care Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2021 ,inter alia, to consider and approve 1. The Audited Financial Results for the quarter and financial year ended 31st March, 2021 and recommendation of dividend, if any. 2. Any other business with permission of the Chair. Further to our intimation to the Stock Exchange vide our letter dated March 30, 2021 for closure of trading window, we would like to inform you that the trading window for dealing in the securities of the Company which was closed from April 01, 2021 will be opened on July 03, 2021 as per the provisions of SEBI (Prohibition of Insider Trading Regulations), 2015. This is for your information and records.
22-06-2021
Bigul

Veerhealth Care Limited - 511523 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Dear Sir, Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), we hereby submit Annual Secretarial Compliance Report for the year ended 31st March, 2021. This is for your information and record.
09-06-2021
Bigul

Veerhealth Care Ltd - 511523 - Compliances - Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 31St March, 2021

 Dear Sir, Pursuant to Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith a Certificate submitted by M/s. Nidhi Shah & Associates, Practicing Company Secretary, for the half year ended March 31, 2021. Kindly consider and take it in your record.
19-04-2021
Bigul

Veerhealth Care Limited - 511523 - Shareholding for the Period Ended March 31, 2021

 Veerhealth Care Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2021. For more details, kindly Click here
15-04-2021
Bigul

Veerhealth Care Ltd - 511523 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Dear Sir, Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, we are hereby submitting the certificate received from M/s. Purva Sharegistry (India) Pvt. Ltd., the Registrar and Share Transfer Agent of the Company, for the quarter ended 31st March, 2021. This is for your information and record.
09-04-2021
Bigul

Veerhealth Care Ltd - 511523 - Compliances-Compliance Certificate For The Period Ended March 31, 2021

 Dear Sir, Pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith a Certificate, duly signed by Share Transfer Agent and the Compliance Officer of the Company for the half year ended March 31, 2021 in compliance of Regulation 7(2) of SEBI Listing Regulations, 2015. Kindly consider and take it in your record.
09-04-2021
Bigul

Veerhealth Care Limited - 511523 - Statement Of Investor Complaints For The Quarter Ended March 2021

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Bhavin S ShahDesignation :- Managing Director / Whole Time Director
07-04-2021
Bigul

Veerhealth Care Limited - 511523 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayVeerhealth Care Limited 2CINL65910MH1992PLC067632 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY Nil 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Rony Shah Designation: Company Secretary EmailId: cs@veerhealthcare.net Name of the Chief Financial Officer: Akash Shah Designation: Chief Financial Officer EmailId: akash@veerhealthcare.net Date: 07/04/2021 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
07-04-2021
Next Page
Close

Let's Open Free Demat Account